Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes

N Engl J Med. 2021 Mar 18;384(11):e42. doi: 10.1056/NEJMc2036175.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Naphthyridines
  • Renal Insufficiency, Chronic* / complications

Substances

  • Naphthyridines
  • finerenone